4/2
Penn in the News
A round-up of Penn mentions in local, national, and international media.
Filter Stories
Penn In the News
Correction is courageous
A study by Kathleen Hall Jamieson of the Annenberg Public Policy Center and colleagues suggests that public trust of a system for correcting errors in the scientific record would go a long way to building trust across ideologies.
Penn In the News
‘Pangenome’ hopes to represent more diverse view of humans
Sarah Tishkoff of the Perelman School of Medicine says that the new pangenome adds structural variants that were previously hard to sequence and analyze.
Penn In the News
Prehistoric carvings depict showdowns between humans and beasts
PIK Professor Lynn Meskell says that newly discovered prehistoric artwork needs to be considered alongside archaeological evidence like food remains, human skeletons, and other artifacts.
Penn In the News
Cell-killing cancer therapy shows promise for a devastating autoimmune disorder
Aimee Payne of the Perelman School of Medicine says that the University of Erlangen-Nürnberg’s new CAR-T therapy lupus research represents a landmark study in the treatment of autoimmunity.
Penn In the News
New private venture tackles the riddle of Long Covid—and aims to test treatments quickly
E. John Wherry of the Perelman School of Medicine says that the Long Covid Research Initiative’s greater risk tolerance and more rapid investment pivoting could enable it to outpace the National Institutes of Health.
Penn In the News
Better fat bubbles could power a new generation of mRNA vaccines
Mohamad-Gabriel Alameh of the Perelman School of Medicine discusses the goal to design ionizable lipids that activate favorable immune pathways without overstimulating detrimental ones.
Penn In the News
Can Trump persuade people to get a COVID-19 shot? Researchers made an ad to find
Katherine Milkman of the Wharton School is quoted on how health communication needs to come from trusted messengers and to meet people where they are.
Penn In the News
First gene-editing treatment injected into the blood reduces toxic protein for up to 1 year
Kiran Musunuru of the Perelman School of Medicine commented on an experimental gene-editing treatment for a condition that has already responded well to approved drugs. “I think people are generally assuming that the clinical outcomes [from the gene-editing treatment] will follow,” he said.
Penn In the News
Oldest human DNA from Africa reveals complex migrations
PIK Professor Sarah Tishkoff said a new analysis of ancient DNA from six individuals from southeastern Africa is a welcome addition to the available genomes, but she expressed some doubts about the researchers’ conclusions. “There’s a lot of assumptions in that analysis,” she said.
Penn In the News
Cash for shots? Studies suggest payouts improve vaccination rates
Dena Gromet of the Wharton School said vaccine incentives like lotteries may be effective, “but we are likely going to have to rely on a multiprong approach to be able to really make a dent in vaccination going forward.”